Taken together, our data indicate that OxPhos-i combined with standard-of-care chemotherapy containing l-asparaginase, with its GLS-inhibitory activity, effectively induces metabolic and transcriptomic cellular catastrophe that impedes leukemia progression and leads to the extension of survival. The gene discussed is GLS; the disease is leukemia.